New catheter aims for more precise liver cancer radiation targeting

NCT ID NCT05743842

Summary

This study is testing whether a specialized catheter called TriNav can make liver cancer radiation treatment planning more accurate. Researchers want to see if using this device helps the test dose better predict where the actual radioactive treatment will go in the liver. The goal is to improve targeting of tumors while protecting healthy liver tissue.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • MD Anderson Cancer Center

    Houston, Texas, 77030, United States

Conditions

Explore the condition pages connected to this study.